Mendelian Randomization Analysis Reveals Causal Relationships Between Circulating Cell Traits and Renal Disorders

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2024 Jun 3

PMID 38828235

Authors

Xing-Yu Shi

Qian-Kun Zhang

Jie Li

Chao-Yong Zhu

Lie Jin

Shipei Fan

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to investigate the causal relationships between circulating cell traits and risk of renal disorders.

Methods: We applied a comprehensive two-sample Mendelian randomization (MR) analysis. Single nucleotide polymorphisms (SNPs) from publicly available genome-wide association studies (GWAS) databases were utilized. Genetically predicted instrumental variables of human blood cell traits were extracted from Blood Cell Consortium (BCX) while data on renal diseases was obtained from Finngen consortium. The primary MR analysis was conducted using the inverse variance weighted (IVW) method, with the weighted median (WM) and MR-Egger models used as additional methods. Sensitivity analyses, including MR-PRESSO, radial regression and MR-Egger intercept were conducted to detect outliers and assess horizontal pleiotropy. We further utilized the leave-one-out analysis to assess the robustness of the results. Causal associations were considered significant based on false rate correction (FDR), specifically when the IVW method provided a < 0.05.

Results: Our results demonstrated that both white blood cell (WBC) count (OR = 1.50, 95% CI = 1.10-2.06, = 0.033, = 0.011) and lymphocyte count (OR = 1.50, 95% CI = 1.13-1.98, = 0.027, = 0.005) were causally associated with a higher risk of IgA nephropathy. Furthermore, WBC count was identified as a significant genetic risk factor for renal malignant neoplasms (OR = 1.23, 95% CI = 1.06-1.43, = 0.041, = 0.007). Additionally, an increased level of genetically predicted eosinophils was found to be causally associated with a higher risk of diabetic nephropathy (OR = 1.21, 95% CI = 1.08-1.36, = 0.007, = 0.001). No evidence of pleiotropy was determined.

Conclusion: Our findings provide evidence of causal associations of circulating WBC count, lymphocyte count and IgA nephropathy, WBC count and renal malignant neoplasms, and eosinophil count and diabetic nephropathy. These results have the potential to contribute to the development of novel diagnostic options and therapeutic strategies for renal disorders.

References

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

Koo T, Kim G, Park M . Clinicopathologic Features of IgA-Dominant Postinfectious Glomerulonephritis. Korean J Pathol. 2012; 46(2):105-14. PMC: 3479780. DOI: 10.4132/KoreanJPathol.2012.46.2.105. View

Ruszkowski J, Lisowska K, Pindel M, Heleniak Z, Debska-Slizien A, Witkowski J . T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target. Clin Exp Nephrol. 2018; 23(3):291-303. PMC: 6394565. DOI: 10.1007/s10157-018-1665-0. View

Lan H, Nikolic-Paterson D, Mu W, Atkins R . Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis. Clin Exp Immunol. 1997; 110(2):233-40. PMC: 2265489. DOI: 10.1111/j.1365-2249.1997.tb08322.x. View

Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J . Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016; 45(6):1961-1974. PMC: 5446088. DOI: 10.1093/ije/dyw220. View

Magistroni R, DAgati V, Appel G, Kiryluk K . New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int. 2015; 88(5):974-89. PMC: 4653078. DOI: 10.1038/ki.2015.252. View

Esteve Cols C, Graterol Torres F, Quirant Sanchez B, Marco Rusinol H, Navarro Diaz M, Rey J . Immunological Pattern in IgA Nephropathy. Int J Mol Sci. 2020; 21(4). PMC: 7073027. DOI: 10.3390/ijms21041389. View

Udani S, Lazich I, Bakris G . Epidemiology of hypertensive kidney disease. Nat Rev Nephrol. 2010; 7(1):11-21. DOI: 10.1038/nrneph.2010.154. View

Burgess S, Thompson S . Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017; 32(5):377-389. PMC: 5506233. DOI: 10.1007/s10654-017-0255-x. View

10.

Zimmet P, Magliano D, Herman W, Shaw J . Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014; 2(1):56-64. DOI: 10.1016/S2213-8587(13)70112-8. View

11.

Skrivankova V, Richmond R, Woolf B, Davies N, Swanson S, VanderWeele T . Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021; 375:n2233. PMC: 8546498. DOI: 10.1136/bmj.n2233. View

12.

Li L, Shen Q, Rao S . Association of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Diabetic Kidney Disease in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study. Ther Clin Risk Manag. 2023; 18:1157-1166. PMC: 9805708. DOI: 10.2147/TCRM.S393135. View

13.

Hofmann J, Hosgood 3rd H, Liu C, Chow W, Shuch B, Cheng W . A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis. 2014; 35(5):1028-31. PMC: 4004202. DOI: 10.1093/carcin/bgt495. View

14.

Rodrigues J, Haas M, Reich H . IgA Nephropathy. Clin J Am Soc Nephrol. 2017; 12(4):677-686. PMC: 5383386. DOI: 10.2215/CJN.07420716. View

15.

Chai L, Cai K, Wang K, Luo Q . Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. J Clin Lab Anal. 2021; 35(6):e23774. PMC: 8183917. DOI: 10.1002/jcla.23774. View

16.

Burgess S, Scott R, Timpson N, Davey Smith G, Thompson S . Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015; 30(7):543-52. PMC: 4516908. DOI: 10.1007/s10654-015-0011-z. View

17.

Rigoni A, Colombo M, Pucillo C . Mast cells, basophils and eosinophils: From allergy to cancer. Semin Immunol. 2018; 35:29-34. DOI: 10.1016/j.smim.2018.02.001. View

18.

Rossi S, Klatte T, Usher-Smith J, Stewart G . Epidemiology and screening for renal cancer. World J Urol. 2018; 36(9):1341-1353. PMC: 6105141. DOI: 10.1007/s00345-018-2286-7. View

19.

Gao Y, Wei Y, Zhou X, Huang S, Zhao H, Zeng P . Assessing the Relationship Between Leukocyte Telomere Length and Cancer Risk/Mortality in UK Biobank and TCGA Datasets With the Genetic Risk Score and Mendelian Randomization Approaches. Front Genet. 2020; 11:583106. PMC: 7644901. DOI: 10.3389/fgene.2020.583106. View

20.

Gallimore A, Tournier C . Immuno-oncology. Essays Biochem. 2023; 67(6):903. DOI: 10.1042/EBC20230071. View